BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4155802)

  • 1. GABA blockade, dopamine and schizophrenia: experimental studies in the cat.
    Stevens J; Wilson K; Foote W
    Psychopharmacologia; 1974; 39(2):105-19. PubMed ID: 4155802
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system.
    Scheel-Krüger J
    Acta Neurol Scand Suppl; 1986; 107():1-54. PubMed ID: 3014800
    [No Abstract]   [Full Text] [Related]  

  • 3. Removal of vestibular commissural inhibition by antagonists of GABA and glycine.
    Precht W; Schwindt PC; Baker R
    Brain Res; 1973 Nov; 62(1):222-6. PubMed ID: 4765112
    [No Abstract]   [Full Text] [Related]  

  • 4. Stereotyped and circling behaviour induced by dopaminergic agonists after lesions of the midbrain raphe nuclei.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1974 Dec; 29(2):206-22. PubMed ID: 4613561
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of haloperidol and clozapine on circling induced by electrical stimulation of the substantia nigra and the ventromedial tegmentum.
    Roffman M; Bernard PS; Dawson KM; Sobiski RE; Saelens JK
    Neuropharmacology; 1978 Nov; 17(11):943-6. PubMed ID: 569257
    [No Abstract]   [Full Text] [Related]  

  • 6. Picrotoxin-like action of bicuculline.
    Banna NR; Naccache A; Jabbur SJ
    Eur J Pharmacol; 1972 Feb; 17(2):301-2. PubMed ID: 4402098
    [No Abstract]   [Full Text] [Related]  

  • 7. Gamma-aminobutyric acid antagonists in crustacea.
    McLennan H
    Can J Physiol Pharmacol; 1973 Oct; 51(10):774-5. PubMed ID: 4753290
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of picrotoxin and bicuculline on the excitation and inhibition of Renshaw cells.
    Piercey MF; Goldfarb J; Ryall RW
    Neuropharmacology; 1973 Oct; 12(10):975-82. PubMed ID: 4750565
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of bicuculline on central inhibition.
    Huffman RD; McFadin LS
    Neuropharmacology; 1972 Nov; 11(6):789-99. PubMed ID: 4638180
    [No Abstract]   [Full Text] [Related]  

  • 10. Glycine and GABA as inhibitory transmitters in the medullary reticular formation. Studies involving intra- and extra-cellular recording.
    Tebécis AK; Ishikawa T
    Pflugers Arch; 1973 Feb; 338(3):273-8. PubMed ID: 4736725
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of the GABA antagonists bicuculline and picrotoxin on primary afferent terminal excitability.
    Levy RA; Anderson EG
    Brain Res; 1972 Aug; 43(1):171-80. PubMed ID: 4340463
    [No Abstract]   [Full Text] [Related]  

  • 12. Bicuculline and picrotoxin sensitive inhibition in interpositus neurones of cat.
    Kawaguchi S; Ono T
    Brain Res; 1973 Aug; 58(1):260-5. PubMed ID: 4354377
    [No Abstract]   [Full Text] [Related]  

  • 13. Electrical sensitization of the meso-limbic dopaminergic system in rats: a pathogenetic model for schizophrenia.
    Glenthøj B; Mogensen J; Laursen H; Holm S; Hemmingsen R
    Brain Res; 1993 Aug; 619(1-2):39-54. PubMed ID: 8374792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that nigral GABA mediates behavioural responses elicited by striatal dopamine receptor stimulation.
    Di Chiara G; Morelli M; Porceddu ML; Gessa GL
    Life Sci; 1978 Nov; 23(20):2045-51. PubMed ID: 569236
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings: CB 154 (2-bromo-alpha-ergokryptine, bromocriptin), a potential anti-Parkinson agent.
    Johnson AM; Vigouret JM; Loew DM
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R40. PubMed ID: 4276573
    [No Abstract]   [Full Text] [Related]  

  • 16. The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral GABAergic pathway.
    Olianas MC; De Montis GM; Mulas G; Tagliamonte A
    Eur J Pharmacol; 1978 Jun; 49(3):233-41. PubMed ID: 566207
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in dopamine agonist and antagonist activity following temporary inactivation of the neostraitum.
    Costall B; Naylor RJ; Pettit JC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(2):103-26. PubMed ID: 4281065
    [No Abstract]   [Full Text] [Related]  

  • 18. Actions of GABA, picrotoxin and bicuculline on adrenal medulla.
    Sangiah S; Borowitz JL; Yim GK
    Eur J Pharmacol; 1974 Jun; 27(1):130-5. PubMed ID: 4850400
    [No Abstract]   [Full Text] [Related]  

  • 19. Substantia nigra as an out-put station for striatal dopaminergic responses: role of a GABA-mediated inhibition of pars reticulata neurons.
    Di Chiara G; Porceddu ML; Morelli M; Mulas ML; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Mar; 306(2):153-9. PubMed ID: 571967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of kainic acid lesions of the striatum on self-stimulation in the substantia nigra and ventral tegmental area.
    Phillips AG; LePiane FG; Fibiger HC
    Behav Brain Res; 1982 Jul; 5(3):297-310. PubMed ID: 6889435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.